Cigna buying Express Scripts for $54B — 6 insights

Cigna intends to purchase Express Scripts for $54 billion, CNBC reports.

Advertisement

Here’s what you should know.

1. CNBC said the move is in response to the CVS-Aetna Health deal which was announced December 2017.

2. Cigna intends to lower healthcare costs by using Express Scripts to increase its purchasing power.

3. Cigna is offering approximately $48.75 and 0.2434 shares of stock in the combined company for each Express Scripts share. It represents approximately $96.03 per share.

4. Cigna would be taking on approximately $15 billion in Express Scripts debt in the transaction.

5. If approved, Cigna shareholders will own 64 percent of the combined company after the deal closes.

6. Cigna CEO David Cordani will serve as the combined company’s CEO.

More articles on coding, billing and collections: 
7 things for ASC leaders to know for Thursday — March 8, 2018
30 statistics on Medicare, Medicaid cases at ASCs
ASC physician workload by region — 21 statistics

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.